TipRanks
Go Ultimate55% OFF

Emcure Pharmaceuticals Limited (EMCURE) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

EMCURE Analyst Ratings

Moderate Buy
1Ratings
1Buy0Hold0Sell
Based on 1 analysts giving stock ratings to Emcure Pharmaceuticals Limited in the past 3 months

EMCURE Stock 12 Month Forecast

INR 2,320.00▲(24.19% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Emcure Pharmaceuticals Limited in the last 3 months. The average price target is INR 2,320.00 with a high forecast of INR 2,320.00 and a low forecast of INR 2,320.00. The average price target represents a 24.19% change from the last price of INR 1,868.10.
Highest Price TargetINR 2,320.00Average Price TargetINR 2,320.00Lowest Price TargetINR 2,320.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for IN:EMCURE
Analyst ProfileExpert FirmPrice TargetPositionUpside / DownsideActionDateFollowArticle
JefferiesINR 2,100→INR 2,320buy24.19%UpsideReiterated08/11/26
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Emcure Pharmaceuticals Limited

3 Months
Alok Dalal
Alok DalalJefferies
Success Rate5/9 ratings generated profit
56%
Average Return
+0.12%

Copying Alok Dalal's trades and holding each position for 3 Months would result in 55.56% of your transactions generating a profit, with an average return of +0.12% per trade.

1 Year
Alok Dalal
Alok DalalJefferies
Success Rate7/9 ratings generated profit
78%
Average Return
+16.10%

Copying Alok Dalal's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +16.10% per trade.

2 Years
Alok Dalal
Alok DalalJefferies
Success Rate7/9 ratings generated profit
78%
Average Return
+19.10%

Copying Alok Dalal's trades and holding each position for 2 Years would result in 77.78% of your transactions generating a profit, with an average return of +19.10% per trade.

EMCURE Analyst Recommendation Trends

00.511.52Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for EMCURE
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy00000
Buy22211
Hold00000
Sell00000
Strong Sell00000
total22211

In the current month, EMCURE has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. EMCURE average Analyst price target in the past 3 months is 2,320.00.

EMCURE Financial Forecast

INR 11INR 12.25INR 13.5INR 14.75INR 16Q3 2026Q1 2027Q2 2027
HighINR 14.90
ConsensusINR 14.90
LowINR 14.90

EMCURE Earnings Forecast

Next quarter’s earnings estimate for EMCURE is INR 14.90 with a range of INR 14.90 to INR 14.90. The previous quarter’s EPS was INR 15.40. EMCURE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year EMCURE has Performed in-line its overall industry.

INR 22.7BINR 23.8BINR 24.8BINR 25.9BINR 27BQ3 2026Q1 2027Q2 2027
HighINR 27B
ConsensusINR 26.6B
LowINR 26.4B

EMCURE Sales Forecast

Next quarter’s sales forecast for EMCURE is INR 26.64B with a range of INR 26.40B to INR 26.95B. The previous quarter’s sales results were INR 25.80B. EMCURE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year EMCURE has Performed in-line its overall industry.

EMCURE Stock Forecast FAQ

What is IN:EMCURE’s average 12-month price target, according to analysts?
Based on analyst ratings, Emcure Pharmaceuticals Limited’s 12-month average price target is ₹2,320.00.
What is IN:EMCURE’s upside potential, based on the analysts’ average price target?
Emcure Pharmaceuticals Limited has 24.19% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Emcure Pharmaceuticals Limited a Buy, Sell or Hold?
Emcure Pharmaceuticals Limited has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Emcure Pharmaceuticals Limited’s share price target?
The average share price target for Emcure Pharmaceuticals Limited is ₹2,320.00. This is based on 1 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is ₹2,320.00, and the lowest forecast is ₹2,320.00. The average share price target represents a 24.19% increase from the current price of ₹1,868.1.
What do analysts say about Emcure Pharmaceuticals Limited?
Emcure Pharmaceuticals Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of Emcure Pharmaceuticals Limited?
To buy shares of IN:EMCURE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.